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LETTERS
Carbapenem-
Resistant
Pseudomonas
aeruginosa–Carrying
VIM-2 Metallo-β-
Lactamase
Determinants,
Croatia 
To the Editor: Carbapenem-
hydrolyzing enzymes of the VIM-
type (six different variants are known:
VIM-1, VIM-2, VIM-3, VIM-4, VIM-
5, and VIM-6) are new molecular
class B metallo-β-lactamases. These
enzymes have recently been identified
in carbapenem-resistant isolates of
Pseudomonas aeruginosa and other
gram-negative nonfermenters from
European countries in the
Mediterranean basin (Italy, France,
Greece, Spain, Portugal, and Turkey),
as well as in Far East countries
(Korea, Taiwan, and Singapore) and
the United States (1–3, Midilli et al.,
GenBank accession no. AY144612,
Koh et al., GenBank accession no.
AY165025). Similar to blaIMP, blaVIM
genes are located on mobile gene cas-
settes inserted in the variable regions
of integrons (1), a condition that pro-
vides a wide potential for expression
and dissemination in gram-negative
pathogens. VIM enzymes possess the
broadest range of substrate hydrolysis
and can degrade virtually all β-lac-
tams, except monobactams (4). 
According to a recent report, the
overall resistance rate to imipenem in
P. aeruginosa isolated from 17 repre-
sentative laboratories in Croatia was
11% (range 0%–20%) (5). However,
molecular basis of carbapenem resist-
ance was not investigated.
In October 2000, two P. aerugi-
nosa isolates with an unusual resist-
ance profile were isolated from two
Croatian patients (66 and 74 years of
age, respectively) who underwent
hysterectomies at the Split University
Hospital. Both isolates were cultured
from urine a week after surgery; a uri-
nary catheter had been used for both
patients who had become febrile and
had signs and symptoms of urinary
tract infection. Analysis of the
macrorestriction profiles of chromoso-
mal DNA of the two isolates by
pulsed-field gel electrophoresis, car-
ried out as described previously (6),
indicated that the two isolates were
clonally related (the two profiles were
apparently identical). In routine antibi-
otic susceptibility testing, done by
disk diffusion, both isolates showed a
multidrug-resistant phenotype, includ-
ing ureidopenicillins, piperacillin,
piperacillin-tazobactam, ceftazidime,
cefoperazone, cefepime, aztreonam,
ciprofloxacin, gentamicin, netilmicin,
imipenem, and meropenem. 
MICs to imipenem and meropen-
em were high (>128 µg/mL). These
findings suggested production of an
acquired carbapenemase. In fact,
crude extracts of the two isolates
exhibited carbapenemase activity in a
spectrophotometric assay (7) (imipen-
em hydrolyzing–specific activity was,
in either case, >170 nmol/min/mg
protein). 
A colony blot hybridization, car-
ried out as described with a blaIMP and
a blaVIM probe (6), yielded a positive
result with the latter probe.
Polymerase chain reaction (PCR)
amplification of the variable region of
class 1 integrons, carried out as
described previously by using primers
designed on the 5′- and 3′-conserved
segments of the integron (8), yielded a
4-kb amplification product from
either isolate. Direct sequencing of
these amplification products showed,
in both cases, the presence of a blaVIM-
2 allele located in a gene cassette
inserted in the attI site of a class 1
integron. 
The metallo-β-lactamase determi-
nant was not transferred to
Escherichia coli MKD135 or P.
aeruginosa 10145/3 (9) in diparental
mating experiments conducted on
solid medium (the sensitivity of the
assay was >1x10-8 transconjugants per
donor). Plasmid extraction was per-
formed with several techniques,
including lysis with sodium dodecyl
sulfate  (10) and alkaline lysis con-
ducted  with a conventional method
(10) or with the Nucleobond BAC100
system (Macherey-Nagel, Duren,
Germany). Extraction of whole
genomic DNA was also performed, as
described (8). Plasmid DNA was not
detected in any of these preparations,
either when analyzed by agarose gel
electrophoresis or after Southern blot
hybridization analysis with a blaVIM-2
probe generated with PCR amplifica-
tion of the entire blaVIM-2 gene. In
Southern blots, a hybridization signal
was only detectable in correspondence
of the band of chromosomal DNA.
To our knowledge, this isolation is
the first one of clinical strains produc-
ing acquired metallo-β-lactamase in
Croatia. Asimilar finding underscores
the progressive emergence of these
determinants in different geographic
areas and emphasizes the need for an
early recognition of these strains. In
fact, monitoring dissemination of new
antibiotic resistance determinants is
essential to enforce adequate control
measures and adjust guidelines for
antimicrobial chemotherapy in differ-
ent hospital settings.
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Rickettsia felis in
the United
Kingdom
To the Editor: Rickettsia felis is a
bacterium transmitted by the cat flea
(Ctenocephalides felis), which also
acts as a reservoir by means of transo-
varial transmission (1–3). The distri-
bution of R. felis is potentially as wide
as that of its insect host, and to date,
its presence has been confirmed in cat
flea populations in North and South
America and southern Europe (4,5).
R. felis was first identified as a human
pathogen in 1994 (6), and cases of
“flea-borne spotted fever,” which
have signs and symptoms of febrile
exanthema, have now been reported
in the United States, Mexico, Brazil,
France, and Germany (7,8). To our
knowledge, reports on the presence of
R. felis, or indeed any other spotted
fever group rickettsia, in the United
Kingdom have not been published.
To determine whether R. felis is
present in the United Kingdom, we
surveyed cat fleas collected from dogs
and cats seen at veterinary practices in
southern England and Northern
Ireland. Atotal of 31 dogs and 79 cats
from veterinary practices in Bristol,
Dorset, London, Devon, Gloucester-
shire, Hampshire, and Antrim were
included in our study. Fleas were col-
lected by combing these animals for
10 minutes. All fleas from each ani-
mal were pooled in 70% ethanol. A
total of 316 Ct. felis (Bouché, 1835),
identified by using accepted morpho-
logic criteria, were obtained, with
each animal yielding one to five fleas.
DNA was extracted from each of the
110 flea pools by using a standard sil-
ica cartridge method (QiaAmp DNA
mini kit, QIAGEN Ltd., Crawley,
West Sussex, U.K.) using the manu-
facturer’s instructions for tissue DNA
extraction. The presence of rickettsial
DNA was determined by using the
polymerase chain reaction (PCR) with
oligonucleotide primers that target
rickettesial  ompB  (5) or gltA (2)
genes. Positive control material was
cultured R. felis. Rigorous controls to
limit contamination were carried out,
including the use of separate, dedicat-
ed rooms for DNA extraction, PCR
setup, and gel analysis. Amplification
products obtained from ompB  and
gltA PCRs were analyzed by using
DNAsequencing. Sequences obtained
were edited by using BioEdit (avail-
able from: URL: http://www.mbio.
mncsu.edu/BioEdit/bioedit.html).
Similarity to published sequences was
determined with the BLAST program
(available from: URL: http://www.
ncbi.nlm.nih.gov) hosted by the
National Centre for Biotechnology
Information.
Eighteen flea DNA pools were
positive for spotted fever group rick-
ettsia. All 18 yielded PCR products
with both ompB  and  gltA-targeting
PCRs. The ompB  and  gltA DNA
sequences of all PCR products were
100% identical to those published for
R. felis, thereby providing evidence
for the presence of R. felis in fleas col-
lected from >16% of the animals sur-
veyed. PCR-positive fleas were col-
lected from 4 dogs and 14 cats from
Bristol, Hampshire, Dorset, and
Northern Ireland. Taking into account
the number of fleas in each pool, we
estimate that 6% to 12% of the fleas
collected were infected with R. felis.
This study represents the first
description of a spotted fever group
rickettsia endemic to the United
Kingdom. The species detected, R.
felis, has clear public health implica-
tions. The bacterium appears to be
widely distributed within the country,
infecting a geographically dispersed
population of Ct. felis. Up to 12% of
Ct. felis may be infected with R. felis,
a flea that is by far the most common
species of ectoparasite encountered
on cats and dogs in the U.K. main-